Pacira BioSciences Inc (PCRX) Reports Record Revenues and Robust Earnings for Full-Year 2023
Company Surpasses 14 Million Patient Mark with EXPAREL and Announces FDA Approvals
Stay updated with breaking news from Frankd Lee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company Surpasses 14 Million Patient Mark with EXPAREL and Announces FDA Approvals
– Findings demonstrate significant reduction in pain and opioid consumption through 96 hours versus active comparator – – Significantly greater proportion of opioid-free patients receiving...
07.02.2024 - TAMPA, Fla., Feb. 07, 2024 (GLOBE NEWSWIRE) - Pacira BioSciences, Inc., (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, has been awarded a national group purchasing agreement ... Seite 1
Bausch Health Announces Board Refreshment
TAMPA, Fla., Jan. 04, 2024 -- Pacira BioSciences, Inc. , the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported preliminary unaudited...